Clinical Trials Summary

Parkinson's Disease - Fluctuators S187.3.002 A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson’s Subjects Receiving Optimized Treatments with Parkinson Medicinal Products Alberto Espay, MD (PI)
Parkinson's Disease - Freezing of gait Medtronic Duration of Effect of Dynamic Visual and Auditory Feedback on Gait in Patients with Parkinson’s Disease Alberto Espay, MD (PI)
Parkinson's Disease - DBS - freezing of gait Investigator Initiated Effect of low versus high frequency subthalamic nucleus deep brain stimulation on freezing of gait in patients with Parkinson’s disease Andrew Duker, MD (PI)
Advanced Parkinson's Disease IPX066-B09-06 A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) in Advanced Parkinson’s Disease Andrew Duker, MD (PI)
Genetics in Parkinson's Disease PaGeR The PaGeR Study: Using Multiplex Families to Map Genes that Modify Susceptibility and Age at Onset in Parkinson’s Disease Fredy J Revilla, MD (PI)
Newly Diagnosed Parkinson's Disease SURE-PD Safety of Urate Elevation in Parkinson's Disease Alberto Espay, MD (PI)
Huntington's Disease 2CARE 2CARE-01.00 CoEnzyme Q10 in Huntington's Disease Fredy J Revilla, MD (PI)
Psychogenic Tremor 10-03-31-04 Psychogenic Tremor: Functional Magnetic Resonance Study of Emotional Processing Alberto Espay, MD (PI)
Psychogenic Dystonia 10-07-09-01 Sensory and emotional processing in Psychogenic Dystonia: a functional magnetic resonance imaging study Alberto Espay, MD (PI)
Huntington's Disease CREST -E Creatine Safety, Tolerability, & Efficacy in Huntington’s Disease Fredy J Revilla, MD (PI)
Exercise in Parkinson's 10110507 The Effect of Strength and Balance Training on Balance and Cognitive Impairments in Parkinson’s Disease Brian Terpstra (PI)
Parkinson's Disease –Newly Diagnosed PPMI 11-12-20-09 Parkinson's Progression Markers Initiative (PPMI) Alberto Espay, MD (PI)